Anyang-si, South Korea

Tae Eun Kim

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Tae Eun Kim in Cancer Treatment

Introduction

Tae Eun Kim is a notable inventor based in Anyang-si, South Korea. He has made significant contributions to the field of cancer treatment, particularly in developing innovative methods to combat interferon beta resistant cancer. With a total of three patents to his name, his work is paving the way for new therapeutic approaches.

Latest Patents

One of his latest patents is a method for treating or sensitizing interferon beta resistant cancer comprising cFLIP siRNA. This invention relates to a pharmaceutical composition that includes an siRNA that binds complementarily to the mRNA of the cFLIP gene. It also incorporates a human interferon beta variant with a specific amino acid sequence at the C-terminus. This composition aims to lower the expression level of cFLIP proteins in resistant cancer cells, promoting apoptosis and enhancing treatment efficacy.

Another patent by Tae Eun Kim focuses on a similar composition for treating or sensitizing interferon beta resistant cancer disease. This invention emphasizes the use of cFLIP siRNA as an active ingredient, which can effectively sensitize cancer cells that show resistance to interferon beta. The innovative approach aims to develop anticancer agents or adjuvants with a new mechanism to improve treatment outcomes.

Career Highlights

Tae Eun Kim has worked with prestigious institutions, including Seoul National University and Abion Inc. His research and innovations have garnered attention in the scientific community, contributing to advancements in cancer therapy.

Collaborations

He has collaborated with notable colleagues such as Young Kee Shin and Jun Young Choi. Their combined expertise has further enhanced the impact of his research in the field of oncology.

Conclusion

Tae Eun Kim's innovative work in developing treatments for interferon beta resistant cancer showcases his commitment to advancing medical science. His patents reflect a significant step forward in cancer therapy, potentially improving the lives of many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…